UMIN000050878
Prospective observational study to evaluate the efficacy of anamorelin on the course of first line chemotherapy in patients with previously-untreated advanced non-small cell lung cancer and cachexia (NEJ050B)
North East Japan Study Group (NEJSG)·University Hospital Medical Information NetworkEnrolling by invitation
Study focus
- Disease/Condition
- Non-small cell lung cancer
- Study type
- Observational
Sponsor & location
- Primary sponsor
- North East Japan Study Group (NEJSG)
- Location
- Japan
Timeline & enrollment
- Phase
- N/A
- Start date
- Mar 31, 2023
- End date
- N/A
ICD-10 classifications
Secondary malignant neoplasm of lungMalignant neoplasm: Lower lobe, bronchus or lungMalignant neoplasm: Middle lobe, bronchus or lungMalignant neoplasm: Bronchus or lung, unspecifiedMalignant neoplasm of bronchus and lung
Data source
- Registry
- University Hospital Medical Information Network
- Trial ID
- UMIN000050878
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for UMIN000050878 through Pure Global AI's free database. This phase not specified trial is sponsored by North East Japan Study Group (NEJSG) and is currently Enrolling by invitation. The study focuses on Non-small cell lung cancer.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to University Hospital Medical Information Network data, helping medical device and pharmaceutical companies navigate clinical research efficiently.